BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19362225)

  • 1. Clinicopathologic significance of DNA mismatch repair defects in endometrial cancer: the devil is in the details.
    Goodfellow PJ
    Gynecol Oncol; 2009 May; 113(2):151-2. PubMed ID: 19362225
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial cancer associated with defective DNA mismatch repair.
    Soliman PT; Lu K
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):701-15, viii. PubMed ID: 18061865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA mismatch repair deficiency in endometrial carcinoma.
    Karamurzin Y; Rutgers JK
    Int J Gynecol Pathol; 2009 May; 28(3):239-55. PubMed ID: 19620942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATR mutations in endometrial cancer: a window into the role of mismatch repair defects.
    Kauff ND
    J Clin Oncol; 2009 Jul; 27(19):3077-8. PubMed ID: 19470916
    [No Abstract]   [Full Text] [Related]  

  • 5. [MICROSATELLITE INSTABILITY IN ENDOMETRIAL CANCER].
    Stoyanov S; Aleksandrova E; Ivanova K; Ignatova M; Gulubova M
    Akush Ginekol (Sofiia); 2015; 54(7):31-5. PubMed ID: 27025106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
    Garg K; Soslow RA
    J Clin Pathol; 2009 Aug; 62(8):679-84. PubMed ID: 19638537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch syndrome in women less than 50 years of age with endometrial cancer.
    Walsh MD; Young J; Spurdle A; Obermair A
    Obstet Gynecol; 2008 Oct; 112(4):943. PubMed ID: 18827140
    [No Abstract]   [Full Text] [Related]  

  • 8. Endometrial cancer and application of proteomics.
    Attarha S; Mints M; Andersson S; Souchelnytskyi S
    Exp Oncol; 2011 Sep; 33(3):174-7. PubMed ID: 21956474
    [No Abstract]   [Full Text] [Related]  

  • 9. Do microsatellite instability profiles really differ between colorectal and endometrial tumors?
    Ferreira AM; Westers H; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; van der Zee AG; Hollema H; Kleibeuker JH; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Jul; 48(7):552-7. PubMed ID: 19373783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approved Use for Keytruda.
    Aschenbrenner DS
    Am J Nurs; 2022 Jul; 122(7):26-27. PubMed ID: 35736598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of estrogen on molecular mechanisms of endometrial carcinogenesis].
    Shiozawa T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():297-302. PubMed ID: 23156260
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenetic mechanisms in endometrial stromal sarcoma.
    Micci F; Heim S
    Cytogenet Genome Res; 2007; 118(2-4):190-5. PubMed ID: 18000370
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancer.
    Reuschenbach M; Sommerer C; Hartschuh W; Zeier M; Doeberitz Mv; Kloor M
    J Invest Dermatol; 2012 Feb; 132(2):491-3. PubMed ID: 22011909
    [No Abstract]   [Full Text] [Related]  

  • 14. Defects in DNA mismatch repair do not account for early-onset basal cell carcinoma.
    Mosterd K; Nellen RG; van Engeland M; van Geel M; van Steensel MA
    Br J Dermatol; 2008 Sep; 159(3):751-3. PubMed ID: 18616788
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA mismatch repair deficient (dMMR) endometrial cancer.
    Liu CH; Yang ST; Wang PH
    Taiwan J Obstet Gynecol; 2022 Sep; 61(5):741-743. PubMed ID: 36088038
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of matriptase and clinical outcome of human endometrial cancer.
    Nakamura K; Hongo A; Kodama J; Abarzua F; Nasu Y; Kumon H; Hiramatsu Y
    Anticancer Res; 2009 May; 29(5):1685-90. PubMed ID: 19443387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
    Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
    J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytogenetics and molecular biology of endometrial stromal sarcoma.
    Sandberg AA
    Cytogenet Genome Res; 2007; 118(2-4):182-9. PubMed ID: 18000369
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.